Roundup, deals, VC Rebecca Zacks wrote: The last week saw a variety of deals across innovation industries in New England, but the biggest ones came from biotech and cleantech. —Ironwood Pharmaceuticals raised $50 million from lead investor Morgan Stanley Investment Management and many of the Cambridge, MA-based biotech’s previous investors. Ironwood plans to use the funds in part to advance linaclotide, a treatment for irritable bowel syndrome, through Phase 3 clinical trials. —Link Medicine
Read more…